Verrica Pharmaceuticals Inc.
VRCA
$5.23
-$0.12-2.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 15.40M | 29.60M | 46.33M | 22.96M | 31.93M |
| Total Receivables | 17.37M | 5.65M | 77.00K | 84.00K | 10.21M |
| Inventory | 2.52M | 2.46M | 2.46M | 2.58M | 2.70M |
| Prepaid Expenses | 1.49M | 1.77M | 2.31M | 2.56M | 2.48M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 36.78M | 39.47M | 51.18M | 28.19M | 47.32M |
|
|
|||||
| Total Current Assets | 36.78M | 39.47M | 51.18M | 28.19M | 47.32M |
| Net Property, Plant & Equipment | 1.95M | 2.33M | 2.58M | 4.20M | 4.24M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 376.00K | 376.00K | 376.00K | 538.00K | 453.00K |
| Total Assets | 39.11M | 42.18M | 54.13M | 32.93M | 52.01M |
|
|
|||||
| Total Accounts Payable | 2.32M | 1.44M | 1.90M | 966.00K | 1.15M |
| Total Accrued Expenses | 3.13M | 3.29M | 3.09M | 6.06M | 4.93M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 13.32M | 13.47M | 13.61M | 1.16M | 1.05M |
| Total Finance Division Other Current Liabilities | 10.46M | 11.20M | 10.42M | 12.84M | 12.92M |
| Total Other Current Liabilities | 10.46M | 11.20M | 10.42M | 12.84M | 12.92M |
| Total Current Liabilities | 29.22M | 29.40M | 29.01M | 21.03M | 20.05M |
|
|
|||||
| Total Current Liabilities | 29.22M | 29.40M | 29.01M | 21.03M | 20.05M |
| Long-Term Debt | 24.58M | 27.81M | 30.98M | 43.31M | 42.75M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 995.00K | 1.16M | 1.35M | 2.65M | 2.51M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.80M | 2.39M | 2.65M | -- | -- |
| Total Liabilities | 56.59M | 60.75M | 63.99M | 66.98M | 65.31M |
|
|
|||||
| Common Stock & APIC | 299.08M | 298.19M | 297.17M | 256.77M | 254.67M |
| Retained Earnings | -316.57M | -316.77M | -307.03M | -290.83M | -267.97M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -17.48M | -18.58M | -9.86M | -34.05M | -13.30M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -17.48M | -18.58M | -9.86M | -34.05M | -13.30M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -17.48M | -18.58M | -9.86M | -34.05M | -13.30M |
|
|
|||||